401k Plan data: BELLICUM PHARMACEUTICALS 401(K) PLAN plan

BELLICUM PHARMACEUTICALS 401(K) PLAN 401k Plan overview

Plan Name	BELLICUM PHARMACEUTICALS 401(K) PLAN
Plan identification number	001

BELLICUM PHARMACEUTICALS 401(K) PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Age/Service Weighted or new comparability or similar plan - Age/Service Weighted Plan: Allocations are based on age, service, or age and service. New comparability or similar plan: Allocations are based on participant classifications and a classification(s) consists entirely or predominantly of highly compensated employees; or the plan provides an additional allocation rate on compensation above a specified threshold, and the theshold or additional rate exceeds the maximum threshold or rate allowed under the permitted disparity rules of section 401(l).
Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Plan provides for automatic enrollment in plan that has employee contributions deducted from payroll.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.

401k Sponsoring company profile

BELLICUM PHARMACEUTICALS, INC. has sponsored the creation of one or more 401k plans.

Company Name: BELLICUM PHARMACEUTICALS, INC.

Employer identification number (EIN): 201450200

NAIC Classification: 325410

Additional information about BELLICUM PHARMACEUTICALS, INC.

Jurisdiction of Incorporation: Texas Secretary of State

Incorporation Date: 2004-08-04

Company Identification Number: 0800372928

Legal Registered Office Address: 3730 KIRBY DR STE 1200

HOUSTON
United States of America (USA)
77098

More information about BELLICUM PHARMACEUTICALS, INC.

Form 5500 Filing Information

Submission information for form 5500 for 401k plan BELLICUM PHARMACEUTICALS 401(K) PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2021-01-01
001 2020-01-01
001 2020-01-01
001 2019-01-01
001 2018-01-01
001 2017-01-01 ANNE FRESE 2018-05-08
001 2016-01-01 ANNE FRESE 2017-05-31
001 2015-01-01 TOM FARRELL 2016-06-21
001 2014-01-01 TOM FARRELL 2015-09-18
001 2013-01-01 TOM FARRELL 2014-06-10

Plan id#	Filing Submission Date	Name of Administrator	Date Administrator Signed
001	2021-01-01
001	2020-01-01
001	2020-01-01
001	2019-01-01
001	2018-01-01
001	2017-01-01	ANNE FRESE	2018-05-08
001	2016-01-01	ANNE FRESE	2017-05-31
001	2015-01-01	TOM FARRELL	2016-06-21
001	2014-01-01	TOM FARRELL	2015-09-18
001	2013-01-01	TOM FARRELL	2014-06-10

Plan Statistics for BELLICUM PHARMACEUTICALS 401(K) PLAN

401k plan membership statisitcs for BELLICUM PHARMACEUTICALS 401(K) PLAN

Measure Date Value
2021: BELLICUM PHARMACEUTICALS 401(K) PLAN 2021 401k membership
Total participants, beginning-of-year 2021-01-01 104
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 0
Number of retired or separated participants receiving benefits 2021-01-01 0
Number of other retired or separated participants entitled to future benefits 2021-01-01 0
Total of all active and inactive participants 2021-01-01 0
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 0
Total participants 2021-01-01 0
Number of participants with account balances 2021-01-01 0
2020: BELLICUM PHARMACEUTICALS 401(K) PLAN 2020 401k membership
Total participants, beginning-of-year 2020-01-01 152
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 17
Number of retired or separated participants receiving benefits 2020-01-01 0
Number of other retired or separated participants entitled to future benefits 2020-01-01 87
Total of all active and inactive participants 2020-01-01 104
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 0
Total participants 2020-01-01 104
Number of participants with account balances 2020-01-01 101
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 0
2019: BELLICUM PHARMACEUTICALS 401(K) PLAN 2019 401k membership
Total participants, beginning-of-year 2019-01-01 184
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 108
Number of retired or separated participants receiving benefits 2019-01-01 0
Number of other retired or separated participants entitled to future benefits 2019-01-01 44
Total of all active and inactive participants 2019-01-01 152
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 0
Total participants 2019-01-01 152
Number of participants with account balances 2019-01-01 132
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 0
2018: BELLICUM PHARMACEUTICALS 401(K) PLAN 2018 401k membership
Total participants, beginning-of-year 2018-01-01 155
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 161
Number of retired or separated participants receiving benefits 2018-01-01 0
Number of other retired or separated participants entitled to future benefits 2018-01-01 20
Total of all active and inactive participants 2018-01-01 181
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 0
Total participants 2018-01-01 181
Number of participants with account balances 2018-01-01 148
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 0

Measure	Date	Value
2021: BELLICUM PHARMACEUTICALS 401(K) PLAN 2021 401k membership
Total participants, beginning-of-year	2021-01-01	104
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	0
Number of retired or separated participants receiving benefits	2021-01-01	0
Number of other retired or separated participants entitled to future benefits	2021-01-01	0
Total of all active and inactive participants	2021-01-01	0
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	0
Total participants	2021-01-01	0
Number of participants with account balances	2021-01-01	0
2020: BELLICUM PHARMACEUTICALS 401(K) PLAN 2020 401k membership
Total participants, beginning-of-year	2020-01-01	152
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	17
Number of retired or separated participants receiving benefits	2020-01-01	0
Number of other retired or separated participants entitled to future benefits	2020-01-01	87
Total of all active and inactive participants	2020-01-01	104
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	0
Total participants	2020-01-01	104
Number of participants with account balances	2020-01-01	101
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	0
2019: BELLICUM PHARMACEUTICALS 401(K) PLAN 2019 401k membership
Total participants, beginning-of-year	2019-01-01	184
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	108
Number of retired or separated participants receiving benefits	2019-01-01	0
Number of other retired or separated participants entitled to future benefits	2019-01-01	44
Total of all active and inactive participants	2019-01-01	152
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	0
Total participants	2019-01-01	152
Number of participants with account balances	2019-01-01	132
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	0
2018: BELLICUM PHARMACEUTICALS 401(K) PLAN 2018 401k membership
Total participants, beginning-of-year	2018-01-01	155
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	161
Number of retired or separated participants receiving benefits	2018-01-01	0
Number of other retired or separated participants entitled to future benefits	2018-01-01	20
Total of all active and inactive participants	2018-01-01	181
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	0
Total participants	2018-01-01	181
Number of participants with account balances	2018-01-01	148
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	0

Financial Data on BELLICUM PHARMACEUTICALS 401(K) PLAN

Measure	Date	Value
2021 : BELLICUM PHARMACEUTICALS 401(K) PLAN 2021 401k financial data
Unrealized appreciation/depreciation of real estate assets	2021-06-14	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2021-06-14	$0
Total unrealized appreciation/depreciation of assets	2021-06-14	$0
Total transfer of assets to this plan	2021-06-14	$0
Total transfer of assets from this plan	2021-06-14	$3,974,133
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-06-14	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-06-14	$0
Expenses. Interest paid	2021-06-14	$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102	2021-06-14	$0
Total income from all sources (including contributions)	2021-06-14	$447,688
Total loss/gain on sale of assets	2021-06-14	$0
Total of all expenses incurred	2021-06-14	$1,739,456
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-06-14	$1,721,637
Expenses. Certain deemed distributions of participant loans	2021-06-14	$0
Value of total corrective distributions	2021-06-14	$3,194
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-06-14	$38,929
Value of total assets at end of year	2021-06-14	$0
Value of total assets at beginning of year	2021-06-14	$5,265,901
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-06-14	$14,625
Total income from rents	2021-06-14	$0
Total interest from all sources	2021-06-14	$145
Total dividends received (eg from common stock, registered investment company shares)	2021-06-14	$14,769
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-06-14	No
Total dividends received from registered investment company shares (eg mutual funds)	2021-06-14	$14,769
Assets. Real estate other than employer real property at end of year	2021-06-14	$0
Assets. Real estate other than employer real property at beginning of year	2021-06-14	$0
Administrative expenses professional fees incurred	2021-06-14	$0
Assets. Corporate prefeered stocks other than exployer securities at end of year	2021-06-14	$0
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2021-06-14	$0
Was this plan covered by a fidelity bond	2021-06-14	Yes
Value of fidelity bond cover	2021-06-14	$500,000
If this is an individual account plan, was there a blackout period	2021-06-14	No
Were there any nonexempt tranactions with any party-in-interest	2021-06-14	No
Contributions received from participants	2021-06-14	$38,929
Participant contributions at end of year	2021-06-14	$0
Participant contributions at beginning of year	2021-06-14	$28,495
Participant contributions at end of year	2021-06-14	$0
Participant contributions at beginning of year	2021-06-14	$0
Assets. Other investments not covered elsewhere at end of year	2021-06-14	$0
Assets. Other investments not covered elsewhere at beginning of year	2021-06-14	$0
Income. Received or receivable in cash from other sources (including rollovers)	2021-06-14	$0
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2021-06-14	$0
Value of other receiveables (less allowance for doubtful accounts) at end of year	2021-06-14	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2021-06-14	$0
Assets. Loans (other than to participants) at end of year	2021-06-14	$0
Assets. Loans (other than to participants) at beginning of year	2021-06-14	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2021-06-14	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2021-06-14	$0
Other income not declared elsewhere	2021-06-14	$0
Administrative expenses (other) incurred	2021-06-14	$14,625
Liabilities. Value of operating payables at end of year	2021-06-14	$0
Liabilities. Value of operating payables at beginning of year	2021-06-14	$0
Total non interest bearing cash at end of year	2021-06-14	$0
Total non interest bearing cash at beginning of year	2021-06-14	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-06-14	No
Income. Non cash contributions	2021-06-14	$0
Value of net income/loss	2021-06-14	$-1,291,768
Value of net assets at end of year (total assets less liabilities)	2021-06-14	$0
Value of net assets at beginning of year (total assets less liabilities)	2021-06-14	$5,265,901
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-06-14	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-06-14	No
Were any leases to which the plan was party in default or uncollectible	2021-06-14	No
Assets. partnership/joint venture interests at end of year	2021-06-14	$0
Assets. partnership/joint venture interests at beginning of year	2021-06-14	$0
Investment advisory and management fees	2021-06-14	$0
Value of interest in registered invesment companies (eg mutual funds) at end of year	2021-06-14	$0
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2021-06-14	$4,984,144
Value of interest in pooled separate accounts at end of year	2021-06-14	$0
Value of interest in pooled separate accounts at beginning of year	2021-06-14	$0
Interest on participant loans	2021-06-14	$171
Income. Interest from loans (other than to participants)	2021-06-14	$0
Interest earned on other investments	2021-06-14	$0
Income. Interest from US Government securities	2021-06-14	$0
Income. Interest from corporate debt instruments	2021-06-14	$0
Value of interest in master investment trust accounts at end of year	2021-06-14	$0
Value of interest in master investment trust accounts at beginning of year	2021-06-14	$0
Value of interest in common/collective trusts at end of year	2021-06-14	$0
Value of interest in common/collective trusts at beginning of year	2021-06-14	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2021-06-14	$0
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2021-06-14	$253,262
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2021-06-14	$253,262
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2021-06-14	$-26
Assets. Value of investments in 103.12 investment entities at end of year	2021-06-14	$0
Assets. Value of investments in 103.12 investment entities at beginning of year	2021-06-14	$0
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2021-06-14	$0
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2021-06-14	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2021-06-14	$0
Asset value of US Government securities at end of year	2021-06-14	$0
Asset value of US Government securities at beginning of year	2021-06-14	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2021-06-14	$393,845
Net investment gain/loss from pooled separate accounts	2021-06-14	$0
Net investment gain or loss from common/collective trusts	2021-06-14	$0
Net gain/loss from 103.12 investment entities	2021-06-14	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-06-14	No
Was there a failure to transmit to the plan any participant contributions	2021-06-14	Yes
Has the plan failed to provide any benefit when due under the plan	2021-06-14	No
Assets. Invements in employer securities at end of year	2021-06-14	$0
Assets. Invements in employer securities at beginning of year	2021-06-14	$0
Assets. Value of employer real property at end of year	2021-06-14	$0
Assets. Value of employer real property at beginning of year	2021-06-14	$0
Contributions received in cash from employer	2021-06-14	$0
Employer contributions (assets) at end of year	2021-06-14	$0
Employer contributions (assets) at beginning of year	2021-06-14	$0
Income. Dividends from preferred stock	2021-06-14	$0
Income. Dividends from common stock	2021-06-14	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-06-14	$1,721,637
Asset. Corporate debt instrument preferred debt at end of year	2021-06-14	$0
Asset. Corporate debt instrument preferred debt at beginning of year	2021-06-14	$0
Asset. Corporate debt instrument debt (other) at end of year	2021-06-14	$0
Asset. Corporate debt instrument debt (other) at beginning of year	2021-06-14	$0
Contract administrator fees	2021-06-14	$0
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2021-06-14	No
Assets. Corporate common stocks other than exployer securities at end of year	2021-06-14	$0
Assets. Corporate common stocks other than exployer securities at beginning of year	2021-06-14	$0
Liabilities. Value of benefit claims payable at end of year	2021-06-14	$0
Liabilities. Value of benefit claims payable at beginning of year	2021-06-14	$0
Assets. Value of buildings and other operty used in plan operation at end of year	2021-06-14	$0
Assets. Value of buildings and other operty used in plan operation at beginning of year	2021-06-14	$0
Did the plan have assets held for investment	2021-06-14	No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-06-14	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-06-14	Yes
Aggregate proceeds on sale of assets	2021-06-14	$0
Aggregate carrying amount (costs) on sale of assets	2021-06-14	$0
Liabilities. Value of acquisition indebtedness at end of year	2021-06-14	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2021-06-14	$0
Opinion of an independent qualified public accountant for this plan	2021-06-14	Unqualified
Accountancy firm name	2021-06-14	CHERRY BEKAERT LLP
Accountancy firm EIN	2021-06-14	560574444
2020 : BELLICUM PHARMACEUTICALS 401(K) PLAN 2020 401k financial data
Unrealized appreciation/depreciation of real estate assets	2020-12-31	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2020-12-31	$0
Total unrealized appreciation/depreciation of assets	2020-12-31	$0
Total transfer of assets to this plan	2020-12-31	$0
Total transfer of assets from this plan	2020-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Expenses. Interest paid	2020-12-31	$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102	2020-12-31	$0
Total income from all sources (including contributions)	2020-12-31	$2,329,126
Total loss/gain on sale of assets	2020-12-31	$0
Total of all expenses incurred	2020-12-31	$2,372,436
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$2,353,221
Expenses. Certain deemed distributions of participant loans	2020-12-31	$0
Value of total corrective distributions	2020-12-31	$0
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$1,148,966
Value of total assets at end of year	2020-12-31	$5,265,901
Value of total assets at beginning of year	2020-12-31	$5,309,211
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$19,215
Total income from rents	2020-12-31	$0
Total interest from all sources	2020-12-31	$3,217
Total dividends received (eg from common stock, registered investment company shares)	2020-12-31	$103,066
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2020-12-31	$103,066
Assets. Real estate other than employer real property at end of year	2020-12-31	$0
Assets. Real estate other than employer real property at beginning of year	2020-12-31	$0
Administrative expenses professional fees incurred	2020-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at end of year	2020-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2020-12-31	$0
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$500,000
If this is an individual account plan, was there a blackout period	2020-12-31	Yes
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Contributions received from participants	2020-12-31	$870,009
Participant contributions at end of year	2020-12-31	$28,495
Participant contributions at beginning of year	2020-12-31	$41,556
Participant contributions at end of year	2020-12-31	$0
Participant contributions at beginning of year	2020-12-31	$0
Assets. Other investments not covered elsewhere at end of year	2020-12-31	$0
Assets. Other investments not covered elsewhere at beginning of year	2020-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2020-12-31	$238,931
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2020-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at end of year	2020-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2020-12-31	$0
Assets. Loans (other than to participants) at end of year	2020-12-31	$0
Assets. Loans (other than to participants) at beginning of year	2020-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2020-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2020-12-31	$0
Other income not declared elsewhere	2020-12-31	$594
Administrative expenses (other) incurred	2020-12-31	$19,215
Liabilities. Value of operating payables at end of year	2020-12-31	$0
Liabilities. Value of operating payables at beginning of year	2020-12-31	$0
Total non interest bearing cash at end of year	2020-12-31	$0
Total non interest bearing cash at beginning of year	2020-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Income. Non cash contributions	2020-12-31	$0
Value of net income/loss	2020-12-31	$-43,310
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$5,265,901
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$5,309,211
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Assets. partnership/joint venture interests at end of year	2020-12-31	$0
Assets. partnership/joint venture interests at beginning of year	2020-12-31	$0
Investment advisory and management fees	2020-12-31	$0
Value of interest in registered invesment companies (eg mutual funds) at end of year	2020-12-31	$4,984,144
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2020-12-31	$0
Value of interest in pooled separate accounts at end of year	2020-12-31	$0
Value of interest in pooled separate accounts at beginning of year	2020-12-31	$5,261,688
Interest on participant loans	2020-12-31	$2,886
Income. Interest from loans (other than to participants)	2020-12-31	$0
Interest earned on other investments	2020-12-31	$0
Income. Interest from US Government securities	2020-12-31	$0
Income. Interest from corporate debt instruments	2020-12-31	$0
Value of interest in master investment trust accounts at end of year	2020-12-31	$0
Value of interest in master investment trust accounts at beginning of year	2020-12-31	$0
Value of interest in common/collective trusts at end of year	2020-12-31	$0
Value of interest in common/collective trusts at beginning of year	2020-12-31	$5,967
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2020-12-31	$253,262
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2020-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2020-12-31	$0
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2020-12-31	$331
Assets. Value of investments in 103.12 investment entities at end of year	2020-12-31	$0
Assets. Value of investments in 103.12 investment entities at beginning of year	2020-12-31	$0
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2020-12-31	$0
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2020-12-31	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2020-12-31	$0
Asset value of US Government securities at end of year	2020-12-31	$0
Asset value of US Government securities at beginning of year	2020-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2020-12-31	$1,772,124
Net investment gain/loss from pooled separate accounts	2020-12-31	$-698,974
Net investment gain or loss from common/collective trusts	2020-12-31	$133
Net gain/loss from 103.12 investment entities	2020-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2020-12-31	No
Assets. Invements in employer securities at end of year	2020-12-31	$0
Assets. Invements in employer securities at beginning of year	2020-12-31	$0
Assets. Value of employer real property at end of year	2020-12-31	$0
Assets. Value of employer real property at beginning of year	2020-12-31	$0
Contributions received in cash from employer	2020-12-31	$40,026
Employer contributions (assets) at end of year	2020-12-31	$0
Employer contributions (assets) at beginning of year	2020-12-31	$0
Income. Dividends from preferred stock	2020-12-31	$0
Income. Dividends from common stock	2020-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$2,353,221
Asset. Corporate debt instrument preferred debt at end of year	2020-12-31	$0
Asset. Corporate debt instrument preferred debt at beginning of year	2020-12-31	$0
Asset. Corporate debt instrument debt (other) at end of year	2020-12-31	$0
Asset. Corporate debt instrument debt (other) at beginning of year	2020-12-31	$0
Contract administrator fees	2020-12-31	$0
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2020-12-31	Yes
Assets. Corporate common stocks other than exployer securities at end of year	2020-12-31	$0
Assets. Corporate common stocks other than exployer securities at beginning of year	2020-12-31	$0
Liabilities. Value of benefit claims payable at end of year	2020-12-31	$0
Liabilities. Value of benefit claims payable at beginning of year	2020-12-31	$0
Assets. Value of buildings and other operty used in plan operation at end of year	2020-12-31	$0
Assets. Value of buildings and other operty used in plan operation at beginning of year	2020-12-31	$0
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Aggregate proceeds on sale of assets	2020-12-31	$0
Aggregate carrying amount (costs) on sale of assets	2020-12-31	$0
Liabilities. Value of acquisition indebtedness at end of year	2020-12-31	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2020-12-31	$0
Opinion of an independent qualified public accountant for this plan	2020-12-31	Disclaimer
Accountancy firm name	2020-12-31	CHERRY BEKAERT LLP
Accountancy firm EIN	2020-12-31	560574444
2019 : BELLICUM PHARMACEUTICALS 401(K) PLAN 2019 401k financial data
Total income from all sources (including contributions)	2019-12-31	$2,315,896
Total income from all sources (including contributions)	2019-12-31	$2,315,896
Total of all expenses incurred	2019-12-31	$1,034,131
Total of all expenses incurred	2019-12-31	$1,034,131
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$1,027,900
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$1,027,900
Value of total corrective distributions	2019-12-31	$3,667
Value of total corrective distributions	2019-12-31	$3,667
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$1,329,087
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$1,329,087
Value of total assets at end of year	2019-12-31	$5,309,211
Value of total assets at end of year	2019-12-31	$5,309,211
Value of total assets at beginning of year	2019-12-31	$4,027,446
Value of total assets at beginning of year	2019-12-31	$4,027,446
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$2,564
Total interest from all sources	2019-12-31	$1,841
Total interest from all sources	2019-12-31	$1,841
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$0
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$0
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$0
Was this plan covered by a fidelity bond	2019-12-31	Yes
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$500,000
Value of fidelity bond cover	2019-12-31	$500,000
If this is an individual account plan, was there a blackout period	2019-12-31	No
If this is an individual account plan, was there a blackout period	2019-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2019-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$1,198,064
Contributions received from participants	2019-12-31	$1,198,064
Participant contributions at end of year	2019-12-31	$41,556
Participant contributions at end of year	2019-12-31	$41,556
Participant contributions at beginning of year	2019-12-31	$18,844
Participant contributions at beginning of year	2019-12-31	$18,844
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$130,513
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$130,513
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2019-12-31	$1,042
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2019-12-31	$1,042
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$1,281,765
Value of net income/loss	2019-12-31	$1,281,765
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$5,309,211
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$5,309,211
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$4,027,446
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$4,027,446
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Value of interest in pooled separate accounts at end of year	2019-12-31	$5,261,688
Value of interest in pooled separate accounts at end of year	2019-12-31	$5,261,688
Value of interest in pooled separate accounts at beginning of year	2019-12-31	$4,004,778
Value of interest in pooled separate accounts at beginning of year	2019-12-31	$4,004,778
Interest on participant loans	2019-12-31	$1,841
Value of interest in common/collective trusts at end of year	2019-12-31	$5,967
Value of interest in common/collective trusts at end of year	2019-12-31	$5,967
Value of interest in common/collective trusts at beginning of year	2019-12-31	$3,824
Value of interest in common/collective trusts at beginning of year	2019-12-31	$3,824
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2019-12-31	$0
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2019-12-31	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2019-12-31	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2019-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$984,968
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$984,968
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	Yes
Was there a failure to transmit to the plan any participant contributions	2019-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Contributions received in cash from employer	2019-12-31	$510
Contributions received in cash from employer	2019-12-31	$510
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$1,026,858
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$1,026,858
Contract administrator fees	2019-12-31	$2,564
Contract administrator fees	2019-12-31	$2,564
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	CHERRY BEKAERT LLP
Accountancy firm name	2019-12-31	CHERRY BEKAERT LLP
Accountancy firm EIN	2019-12-31	560574444
Accountancy firm EIN	2019-12-31	560574444
2018 : BELLICUM PHARMACEUTICALS 401(K) PLAN 2018 401k financial data
Total income from all sources (including contributions)	2018-12-31	$943,907
Total of all expenses incurred	2018-12-31	$931,060
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$929,620
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$1,232,249
Value of total assets at end of year	2018-12-31	$4,027,446
Value of total assets at beginning of year	2018-12-31	$4,014,599
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$1,440
Total interest from all sources	2018-12-31	$1,168
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$400,000
If this is an individual account plan, was there a blackout period	2018-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2018-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$917,417
Participant contributions at end of year	2018-12-31	$18,844
Participant contributions at beginning of year	2018-12-31	$26,415
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$314,832
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$12,847
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$4,027,446
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$4,014,599
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Value of interest in pooled separate accounts at end of year	2018-12-31	$4,004,778
Value of interest in pooled separate accounts at beginning of year	2018-12-31	$3,918,607
Interest on participant loans	2018-12-31	$1,168
Value of interest in common/collective trusts at end of year	2018-12-31	$3,824
Value of interest in common/collective trusts at beginning of year	2018-12-31	$69,577
Net investment gain/loss from pooled separate accounts	2018-12-31	$-289,611
Net investment gain or loss from common/collective trusts	2018-12-31	$101
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$929,620
Contract administrator fees	2018-12-31	$1,440
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	PMB HELIN DONOVAN, LLP
Accountancy firm EIN	2018-12-31	743001153

Form 5500 Responses for BELLICUM PHARMACEUTICALS 401(K) PLAN

2021: BELLICUM PHARMACEUTICALS 401(K) PLAN 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	Submission has been amended	No
2021-01-01	This submission is the final filing	Yes
2021-01-01	This return/report is a short plan year return/report (less than 12 months)	Yes
2021-01-01	Plan is a collectively bargained plan	No
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: BELLICUM PHARMACEUTICALS 401(K) PLAN 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	Submission has been amended	Yes
2020-01-01	This submission is the final filing	No
2020-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2020-01-01	Plan is a collectively bargained plan	No
2020-01-01	Plan funding arrangement – Insurance	Yes
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement – Insurance	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: BELLICUM PHARMACEUTICALS 401(K) PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Plan funding arrangement – Insurance	Yes
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: BELLICUM PHARMACEUTICALS 401(K) PLAN 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Plan funding arrangement – Insurance	Yes
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes

Insurance Providers Used on plan

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

459149

Policy instance

Insurance contract or identification number	459149
Number of Individuals Covered	0
Insurance policy start date	2020-01-01
Insurance policy end date	2020-03-15
Are there contracts with allocated funds for individual policies?	0
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	No
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

459149

Policy instance

Insurance contract or identification number	459149
Number of Individuals Covered	166
Insurance policy start date	2019-01-01
Insurance policy end date	2019-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $3,582
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Commission paid to Insurance Broker	USD $0
Amount paid for insurance broker fees	3582
Additional information about fees paid to insurance broker	REFERRAL/SERVICE FEE
Insurance broker organization code?	5

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

459149

Policy instance

Insurance contract or identification number	459149
Number of Individuals Covered	187
Insurance policy start date	2018-01-01
Insurance policy end date	2018-12-31
Total amount of fees paid to insurance company	USD $3,382
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Amount paid for insurance broker fees	3382
Additional information about fees paid to insurance broker	TPA COMPENSATION
Insurance broker organization code?	5

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	BELLICUM PHARMACEUTICALS, INC.
Employer identification number (EIN):	201450200
NAIC Classification:	325410

Jurisdiction of Incorporation:	Texas Secretary of State
Incorporation Date:	2004-08-04
Company Identification Number:	0800372928
Legal Registered Office Address:	3730 KIRBY DR STE 1200 HOUSTON United States of America (USA) 77098